EZH2 in Bladder Cancer, a Promising Therapeutic Target

By Martínez-Fernández Mónica   Rubio Carolina   Segovia Cristina   López-Calderón Fernando F.   Dueñas Marta   Paramio Jesús M.  

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 27107-27132

MDPI

Access to resources Recommend Favorite

Cancer Development, Progression, and Therapy: An Epigenetic Overview

By Sarkar Sibaji   Horn Garrick   Moulton Kimberly   Oza Anuja   Byler Shannon   Kokolus Shannon   Longacre McKenna  

International Journal of Molecular Sciences, Vol. 14, Iss. 10, 2013-10 ,pp. : 21087-21113

MDPI

Access to resources Recommend Favorite

Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells

By Li Kuiqing   Liu Cheng   Zhou Bangfen   Bi Liangkuan   Huang Hai   Lin Tianxin   Xu Kewei  

International Journal of Molecular Sciences, Vol. 14, Iss. 6, 2013-06 ,pp. : 11981-11993

MDPI

Access to resources Recommend Favorite

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy

By Castilho Rogerio M.   Squarize Cristiane H.   Almeida Luciana O.  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1506-1506

MDPI

Access to resources Recommend Favorite

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy

By Song In-Sung   Kim Hyoung-Kyu   Jeong Seung-Hun   Lee Sung-Ryul   Kim Nari   Rhee Byoung Doo   Ko Kyung Soo   Han Jin  

International Journal of Molecular Sciences, Vol. 12, Iss. 10, 2011-10 ,pp. : 7163-7185

MDPI

Access to resources Recommend Favorite